aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
4.320
-0.110 (-2.48%)
At close: Feb 21, 2025, 4:00 PM
4.466
+0.146 (3.37%)
After-hours: Feb 21, 2025, 7:49 PM EST
aTyr Pharma Employees
As of December 31, 2023, aTyr Pharma had 59 total employees, including 56 full-time and 3 part-time employees. The number of employees decreased by 11 or -15.71% compared to the previous year.
Employees
59
Change (1Y)
-11
Growth (1Y)
-15.71%
Revenue / Employee
$3,983
Profits / Employee
-$1,081,627
Market Cap
362.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ATYR News
- 24 days ago - aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors - GlobeNewsWire
- 2 months ago - aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis - GlobeNewsWire
- 3 months ago - aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis - GlobeNewsWire
- 4 months ago - aTyr Pharma: The Bull Has Finally Come Out - Seeking Alpha
- 4 months ago - aTyr Pharma to Present at the LD Micro Main Event XVII in October - Newsfile Corp
- 5 months ago - aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point - Seeking Alpha
- 6 months ago - aTyr Pharma to Participate in September Investor Conferences - GlobeNewsWire